Cargando…
The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure
BACKGROUND: Mental health illnesses are associated with frequent hospitalisation and an increased risk of all-cause mortality. Despite the high prevalence of depression in patients with chronic heart failure (CHF), there is a paucity of data on this subject from low and middle-income countries (LMIC...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114712/ https://www.ncbi.nlm.nih.gov/pubmed/33980322 http://dx.doi.org/10.1186/s13033-021-00467-x |
_version_ | 1783691105863204864 |
---|---|
author | Tsabedze, Nqoba Kinsey, Jamie-Leigh Hayes Mpanya, Dineo Mogashoa, Vanessa Klug, Eric Manga, Pravin |
author_facet | Tsabedze, Nqoba Kinsey, Jamie-Leigh Hayes Mpanya, Dineo Mogashoa, Vanessa Klug, Eric Manga, Pravin |
author_sort | Tsabedze, Nqoba |
collection | PubMed |
description | BACKGROUND: Mental health illnesses are associated with frequent hospitalisation and an increased risk of all-cause mortality. Despite the high prevalence of depression in patients with chronic heart failure (CHF), there is a paucity of data on this subject from low and middle-income countries (LMIC). The aim of this study was to determine the prevalence of depression, anxiety, and stress symptoms in patients attending a dedicated CHF clinic. METHODS: A prospective study was conducted at an outpatient heart failure clinic in a tertiary academic centre. The study participants completed a Depression, Anxiety and Stress (DASS-21) questionnaire to screen for the presence and severity of depression, anxiety and stress symptoms. Furthermore, the Minnesota Living with Heart Failure Questionnaire (MLHFQ) was completed and used to evaluate the impact of CHF on health-related quality of life (QoL). Descriptive statistics were used to describe patients' characteristics and logistic regression analysis to identify predictors of symptoms of depression. RESULTS: The study population comprised of 103 patients, predominantly female (62.1%) with a median age of 53 (interquartile range 38–61) years. Symptoms of depression were reported by 52.4%, with 11.6% reporting symptoms suggestive of extremely severe depression. Anxiety was diagnosed in 53.4% of patients and extremely severe anxiety was reported by 18.4% of patients. Fifty patients were classified as stressed, and only 7.7% had extremely severe stress. More than half of the patients (54.4%) were in New York Heart Association functional class I. The mean left ventricular ejection fraction in the entire cohort was 30% (SD = ± 11.1%). In the multivariable logistic regression model, the MLHFQ score [odds ratio (OR) 1.04, 95% CI:1.02–1.06, p = 0.001] and the six-minute walk test [OR 0.99, 95% CI: 0.98–0.99, p = 0.014] were identified as independent predictors of depression. CONCLUSION: Depression and anxiety symptoms were found in over half of patients attending the CHF clinic. We recommend that mental health screening should be routinely performed in patients with CHF. Prospective, adequately powered, multicentre studies from LMIC investigating the impact of depression, anxiety and stress on CHF outcomes such as health-related QoL, hospitalisation and mortality are required. |
format | Online Article Text |
id | pubmed-8114712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81147122021-05-12 The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure Tsabedze, Nqoba Kinsey, Jamie-Leigh Hayes Mpanya, Dineo Mogashoa, Vanessa Klug, Eric Manga, Pravin Int J Ment Health Syst Research BACKGROUND: Mental health illnesses are associated with frequent hospitalisation and an increased risk of all-cause mortality. Despite the high prevalence of depression in patients with chronic heart failure (CHF), there is a paucity of data on this subject from low and middle-income countries (LMIC). The aim of this study was to determine the prevalence of depression, anxiety, and stress symptoms in patients attending a dedicated CHF clinic. METHODS: A prospective study was conducted at an outpatient heart failure clinic in a tertiary academic centre. The study participants completed a Depression, Anxiety and Stress (DASS-21) questionnaire to screen for the presence and severity of depression, anxiety and stress symptoms. Furthermore, the Minnesota Living with Heart Failure Questionnaire (MLHFQ) was completed and used to evaluate the impact of CHF on health-related quality of life (QoL). Descriptive statistics were used to describe patients' characteristics and logistic regression analysis to identify predictors of symptoms of depression. RESULTS: The study population comprised of 103 patients, predominantly female (62.1%) with a median age of 53 (interquartile range 38–61) years. Symptoms of depression were reported by 52.4%, with 11.6% reporting symptoms suggestive of extremely severe depression. Anxiety was diagnosed in 53.4% of patients and extremely severe anxiety was reported by 18.4% of patients. Fifty patients were classified as stressed, and only 7.7% had extremely severe stress. More than half of the patients (54.4%) were in New York Heart Association functional class I. The mean left ventricular ejection fraction in the entire cohort was 30% (SD = ± 11.1%). In the multivariable logistic regression model, the MLHFQ score [odds ratio (OR) 1.04, 95% CI:1.02–1.06, p = 0.001] and the six-minute walk test [OR 0.99, 95% CI: 0.98–0.99, p = 0.014] were identified as independent predictors of depression. CONCLUSION: Depression and anxiety symptoms were found in over half of patients attending the CHF clinic. We recommend that mental health screening should be routinely performed in patients with CHF. Prospective, adequately powered, multicentre studies from LMIC investigating the impact of depression, anxiety and stress on CHF outcomes such as health-related QoL, hospitalisation and mortality are required. BioMed Central 2021-05-12 /pmc/articles/PMC8114712/ /pubmed/33980322 http://dx.doi.org/10.1186/s13033-021-00467-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tsabedze, Nqoba Kinsey, Jamie-Leigh Hayes Mpanya, Dineo Mogashoa, Vanessa Klug, Eric Manga, Pravin The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title | The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title_full | The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title_fullStr | The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title_full_unstemmed | The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title_short | The prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
title_sort | prevalence of depression, stress and anxiety symptoms in patients with chronic heart failure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114712/ https://www.ncbi.nlm.nih.gov/pubmed/33980322 http://dx.doi.org/10.1186/s13033-021-00467-x |
work_keys_str_mv | AT tsabedzenqoba theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT kinseyjamieleighhayes theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mpanyadineo theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mogashoavanessa theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT klugeric theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mangapravin theprevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT tsabedzenqoba prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT kinseyjamieleighhayes prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mpanyadineo prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mogashoavanessa prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT klugeric prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure AT mangapravin prevalenceofdepressionstressandanxietysymptomsinpatientswithchronicheartfailure |